Selected research
Industry Research
Coagulation Albumin Industry Research Report 2026
Market perspective
The global Coagulation Albumin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Coagulation Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Coagulation Albumin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Coagulation Albumin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Coagulation Albumin include Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Baxter, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Coagulation Albumin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coagulation Albumin Market by Company
Sichuan Yuanda Shuyang
Shanghai RAAS
Hualan Bio
Baxter
Octapharma
LFB Group
Kedrion
Grifols
CSL
CNBG
CBPO
BPL
Biotest
Coagulation Albumin Segment by Type
Liquid Coagulation Albumin
Powder Coagulation Albumin
Coagulation Albumin Segment by Application
Infectious Hepatitis
Measles
Other
Coagulation Albumin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coagulation Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Coagulation Albumin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Coagulation Albumin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Coagulation Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Coagulation Albumin
- Powder Coagulation Albumin
Applications
- Infectious Hepatitis
- Measles
- Other
Companies covered
- Sichuan Yuanda Shuyang
- Shanghai RAAS
- Hualan Bio
- Baxter
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CNBG
- CBPO
- BPL
- Biotest
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Coagulation Albumin Market Size (2021-2032)
- 2.2.2 Global Coagulation Albumin Sales (2021-2032)
- 2.2.3 Global Coagulation Albumin Market Average Price (2021-2032)
- 2.3 Coagulation Albumin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid Coagulation Albumin
- 2.3.3 Powder Coagulation Albumin
- 2.4 Coagulation Albumin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infectious Hepatitis
- 2.4.3 Measles
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Coagulation Albumin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Coagulation Albumin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Coagulation Albumin Revenue of Manufacturers (2021-2026)
- 3.4 Global Coagulation Albumin Average Price by Manufacturers (2021-2026)
- 3.5 Global Coagulation Albumin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Coagulation Albumin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Coagulation Albumin, Product Type & Application
- 3.8 Global Manufacturers of Coagulation Albumin, Established Date
- 3.9 Global Coagulation Albumin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Yuanda Shuyang
- 4.1.1 Sichuan Yuanda Shuyang Company Information
- 4.1.2 Sichuan Yuanda Shuyang Business Overview
- 4.1.3 Sichuan Yuanda Shuyang Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Yuanda Shuyang Coagulation Albumin Product Portfolio
- 4.1.5 Sichuan Yuanda Shuyang Recent Developments
- 4.2 Shanghai RAAS
- 4.2.1 Shanghai RAAS Company Information
- 4.2.2 Shanghai RAAS Business Overview
- 4.2.3 Shanghai RAAS Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai RAAS Coagulation Albumin Product Portfolio
- 4.2.5 Shanghai RAAS Recent Developments
- 4.3 Hualan Bio
- 4.3.1 Hualan Bio Company Information
- 4.3.2 Hualan Bio Business Overview
- 4.3.3 Hualan Bio Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hualan Bio Coagulation Albumin Product Portfolio
- 4.3.5 Hualan Bio Recent Developments
- 4.4 Baxter
- 4.4.1 Baxter Company Information
- 4.4.2 Baxter Business Overview
- 4.4.3 Baxter Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter Coagulation Albumin Product Portfolio
- 4.4.5 Baxter Recent Developments
- 4.5 Octapharma
- 4.5.1 Octapharma Company Information
- 4.5.2 Octapharma Business Overview
- 4.5.3 Octapharma Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Octapharma Coagulation Albumin Product Portfolio
- 4.5.5 Octapharma Recent Developments
- 4.6 LFB Group
- 4.6.1 LFB Group Company Information
- 4.6.2 LFB Group Business Overview
- 4.6.3 LFB Group Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LFB Group Coagulation Albumin Product Portfolio
- 4.6.5 LFB Group Recent Developments
- 4.7 Kedrion
- 4.7.1 Kedrion Company Information
- 4.7.2 Kedrion Business Overview
- 4.7.3 Kedrion Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kedrion Coagulation Albumin Product Portfolio
- 4.7.5 Kedrion Recent Developments
- 4.8 Grifols
- 4.8.1 Grifols Company Information
- 4.8.2 Grifols Business Overview
- 4.8.3 Grifols Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Grifols Coagulation Albumin Product Portfolio
- 4.8.5 Grifols Recent Developments
- 4.9 CSL
- 4.9.1 CSL Company Information
- 4.9.2 CSL Business Overview
- 4.9.3 CSL Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CSL Coagulation Albumin Product Portfolio
- 4.9.5 CSL Recent Developments
- 4.10 CNBG
- 4.10.1 CNBG Company Information
- 4.10.2 CNBG Business Overview
- 4.10.3 CNBG Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CNBG Coagulation Albumin Product Portfolio
- 4.10.5 CNBG Recent Developments
- 4.11 CBPO
- 4.11.1 CBPO Company Information
- 4.11.2 CBPO Business Overview
- 4.11.3 CBPO Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CBPO Coagulation Albumin Product Portfolio
- 4.11.5 CBPO Recent Developments
- 4.12 BPL
- 4.12.1 BPL Company Information
- 4.12.2 BPL Business Overview
- 4.12.3 BPL Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BPL Coagulation Albumin Product Portfolio
- 4.12.5 BPL Recent Developments
- 4.13 Biotest
- 4.13.1 Biotest Company Information
- 4.13.2 Biotest Business Overview
- 4.13.3 Biotest Coagulation Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Biotest Coagulation Albumin Product Portfolio
- 4.13.5 Biotest Recent Developments
5 Global Coagulation Albumin Market Scenario by Region
- 5.1 Global Coagulation Albumin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Coagulation Albumin Sales by Region: 2021-2032
- 5.2.1 Global Coagulation Albumin Sales by Region: 2021-2026
- 5.2.2 Global Coagulation Albumin Sales by Region: 2027-2032
- 5.3 Global Coagulation Albumin Revenue by Region: 2021-2032
- 5.3.1 Global Coagulation Albumin Revenue by Region: 2021-2026
- 5.3.2 Global Coagulation Albumin Revenue by Region: 2027-2032
- 5.4 North America Coagulation Albumin Market Facts & Figures by Country
- 5.4.1 North America Coagulation Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Coagulation Albumin Sales by Country (2021-2032)
- 5.4.3 North America Coagulation Albumin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Coagulation Albumin Market Facts & Figures by Country
- 5.5.1 Europe Coagulation Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Coagulation Albumin Sales by Country (2021-2032)
- 5.5.3 Europe Coagulation Albumin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Coagulation Albumin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Coagulation Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Coagulation Albumin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Coagulation Albumin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Coagulation Albumin Market Facts & Figures by Country
- 5.7.1 South America Coagulation Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Coagulation Albumin Sales by Country (2021-2032)
- 5.7.3 South America Coagulation Albumin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Coagulation Albumin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Coagulation Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Coagulation Albumin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Coagulation Albumin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Coagulation Albumin Sales by Type (2021-2032)
- 6.1.1 Global Coagulation Albumin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Coagulation Albumin Sales Market Share by Type (2021-2032)
- 6.2 Global Coagulation Albumin Revenue by Type (2021-2032)
- 6.2.1 Global Coagulation Albumin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Coagulation Albumin Revenue Market Share by Type (2021-2032)
- 6.3 Global Coagulation Albumin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Coagulation Albumin Sales by Application (2021-2032)
- 7.1.1 Global Coagulation Albumin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Coagulation Albumin Sales Market Share by Application (2021-2032)
- 7.2 Global Coagulation Albumin Revenue by Application (2021-2032)
- 7.2.1 Global Coagulation Albumin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Coagulation Albumin Revenue Market Share by Application (2021-2032)
- 7.3 Global Coagulation Albumin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Coagulation Albumin Value Chain Analysis
- 8.1.1 Coagulation Albumin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Coagulation Albumin Production Mode & Process
- 8.2 Coagulation Albumin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Coagulation Albumin Distributors
- 8.2.3 Coagulation Albumin Customers
9 Global Coagulation Albumin Analyzing Market Dynamics
- 9.1 Coagulation Albumin Industry Trends
- 9.2 Coagulation Albumin Industry Drivers
- 9.3 Coagulation Albumin Industry Opportunities and Challenges
- 9.4 Coagulation Albumin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst